Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridine — H.J. Keizer (1994) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridine
Shared by
De Clercq Erik
KU Leuven
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2′-deoxyuridine
Article
1994
en
Authors
+1 more
HK
H.J. Keizer
EB
E. A. de Bruijn
UT
U.R. Tjaden
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1984
The antiviral spectrum of (E)-5-(2-bromovinyl)-2 '-deoxyuridine
De Clercq Erik
Article
1983
Inhibition of terminal deoxynucleotidyltransferase by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
Ono K
,
Hideo Nakane
,
Luciane Maria Colla
,
De Clercq Erik
Article
1985
Inhibition and reversal of the degradation of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo
Claude Des̀granges
,
G Razaka
,
H Bricaud
,
De Clercq Erik
Article
1984
Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.
Claude Des̀granges
,
G Razaka
,
F Drouillet
,
H Bricaud
,
Piet Herdewijn
,
De Clercq Erik
Article
1981
On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.
H.S. Allaudeen
,
John W. Kozarich
,
Joseph R. Bertino
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.